Duvyzat (givinostat) Coverage Criteria
Customize your policy alerts
Sign up for all UnitedHealthcare policy alerts
Know when UnitedHealthcare releases new policies or updates existing guidance.
Monitor payer policy activity
This policy governs UnitedHealthcare prior authorization and reauthorization for Duvyzat oral suspension for Duchenne muscular dystrophy in patients 6 years of age or older, subject to stated clinical criteria, benefit terms, and applicable utilization-management processes.
The policy underwent an annual review with no changes to the coverage criteria, and the reference information was updated.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.